Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells

BACKGROUND: Cisplatin (CDDP) is the most frequently used chemotherapeutic agent for various types of advanced cancer, including gastric cancer. However, almost all cancer cells acquire resistance against CDDP, and this phenomenon adversely affects prognosis. Thus, new chemotherapeutic agents that ca...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Tanaka, Mamoru, Kataoka, Hiromi, Yano, Shigenobu, Ohi, Hiromi, Kawamoto, Keisuke, Shibahara, Takashi, Mizoshita, Tsutomu, Mori, Yoshinori, Tanida, Satoshi, Kamiya, Takeshi, Joh, Takashi
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2013
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659059/
https://ncbi.nlm.nih.gov/pubmed/23672493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-237
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים